stockrowPraxis Precision Medicines, Inc.
PRAX Healthcare Biotechnology
Praxis Precision Medicines, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $8.6 million, up 249.5% from fiscal 2023.
- Revenue
- +1,349.1%
- EPS
- +13.3%
- Free cash flow
- −43.5%
Quarter to June 2026, against a year earlier
Follow PRAX
Alert me
Praxis Precision Medicines, Inc. (PRAX) Gross margin
Praxis Precision Medicines, Inc.'s gross margin over the twelve months to 31 December 2024 was 100.0%. Over the past ten years it has ranged from 0.00% (fiscal 2022) to 100.0% (fiscal 2024) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 65.2% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2024 | 100.0% | 0.00 |
| FY2023 | 100.0% | 100.00 |
| FY2022 | 0.00% | 0.00 |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Dec 2024 | 100.0% | 0.00 |
| Sep 2024 | 100.0% | 0.00 |
| Jun 2024 | 100.0% | 0.00 |
| Mar 2024 | 100.0% | 0.00 |
| 17 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ARWR Arrowhead Pharmaceuticals, Inc. compare | 100.0% |
| PRAX Praxis Precision Medicines, Inc. | 100.0% |
| SYRE Spyre Therapeutics, Inc. compare | 100.0% |
| CORT Corcept Therapeutics Incorporated compare | 98.5% |
| KRYS Krystal Biotech, Inc. compare | 94.3% |
| AXSM Axsome Therapeutics, Inc. compare | 93.3% |
| RYTM Rhythm Pharmaceuticals, Inc. compare | 88.2% |
| CYTK Cytokinetics, Incorporated compare | 0.00% |
| ABVX Abivax SA Sponsored ADR compare | 0.00% |
| Biotechnology industry median | 65.2% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue